Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials

BACKGROUND: OnabotulinumtoxinA is a novel therapeutic intervention whose mechanism of action is believed to modify the negative facial feedback, thus abating symptoms of depression. This putative new antidepressant agent offers minimal systemic side effects and negligible risk of pharmacological int...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnone, Danilo, Galadari, Hassan, Rodgers, Carl J, Östlundh, Linda, Aziz, Karim Abdel, Stip, Emmanuel, Young, Allan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366169/
https://www.ncbi.nlm.nih.gov/pubmed/33719696
http://dx.doi.org/10.1177/0269881121991827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366169/
https://www.ncbi.nlm.nih.gov/pubmed/33719696
http://dx.doi.org/10.1177/0269881121991827

Ejemplares similares